DTNBP1: A Potential Drug Target and Biomarker for Various Diseases

Target Name: DTNBP1

NCBI ID: G84062

DTNBP1

DTNBP1: A Potential Drug Target and Biomarker for Various Diseases

DTNBP1 (Dietrichius-Tunin-Bromley-Protein 1) is a gene that encodes a protein located in the endoplasmic reticulum (ER) of the cell. The ER is a membrane-wrapped organelle, responsible for protein synthesis, modification, and storage.DTNBP1 is a 21 kDa protein that is expressed in most tissues and cells, but its function and specificity are not well understood.

DTNBP1 has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its potential as a drug target is based on its unique structure, which allows it to interact with small molecules, including drugs , with high affinity.DTNBP1 can also be used as a biomarker for disease diagnosis and monitoring, as its expression levels can be easily measured and its function can be studied in cell culture models and animal models.

DTNBP1 is a member of the wash superfamily, which includes other proteins that are involved in protein transport and modification. These proteins are characterized by a conserved N-terminal region that includes a putative transmembrane domain and a C-terminal region that is involved in protein-protein interactions and in localizing to the ER. The wash superfamily also includes a C-terminal region that is involved in protein stability and a N-terminal region that includes a putative cytoplasmic localization domain.

DTNBP1 is expressed in most tissues and cells and has been shown to be involved in various cellular processes, including cell signaling, protein synthesis and modification, and stress response. It is a component of several signaling pathways, including the TOR signaling pathway, the PI3K /Akt signaling pathway, and the stress response pathway. It is also involved in the regulation of cellular processes such as cell adhesion, migration and invasion, and cell survival.

DTNBP1 has been shown to interact with several small molecules, including drugs that are currently used to treat various diseases. Its affinity for small molecules makes it a potential drug target.DTNBP1 can interact with small molecules such as rapamycin, a drug that is used to treat cancer and other diseases, with high affinity. This interaction allowsDTNBP1 to be targeted by drugs that are used to treat similar diseases, such as cancer.

In addition to its potential as a drug target, DTNBP1 has also been identified as a biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its expression levels can be easily measured, and its function can be studied in cell culture models and animal models. This makes it a valuable tool for disease diagnosis and monitoring.

DTNBP1 has been shown to play a role in the regulation of cellular processes that are important for disease progression. For example, it has been shown to be involved in the regulation of cell adhesion, a process that is important for tumor cell growth and the development of invasive tumors. It is also involved in the regulation of cell migration and invasion, which are processes that are important for the development of cancer.

In addition to its role in disease progression, DTNBP1 has also been shown to play a role in the regulation of cellular processes that are important for tissue repair and regeneration. For example, it is involved in the regulation of cell proliferation, cell survival and cell death, which are processes that are important for tissue repair and regeneration.

DTNBP1 is also involved in the regulation of cellular processes that are important for stress response. It is a component of several signaling pathways that are involved in stress response, including the TOR signaling pathway, the PI3K/Akt signaling pathway and

Protein Name: Dystrobrevin Binding Protein 1

Functions: Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Associates with the BLOC-2 complex to facilitate the transport of TYRP1 independent of AP-3 function. Plays a role in synaptic vesicle trafficking and in neurotransmitter release. Plays a role in the regulation of cell surface exposure of DRD2. May play a role in actin cytoskeleton reorganization and neurite outgrowth. May modulate MAPK8 phosphorylation. Appears to promote neuronal transmission and viability through regulating the expression of SNAP25 and SYN1, modulating PI3-kinase-Akt signaling and influencing glutamatergic release. Regulates the expression of SYN1 through binding to its promoter. Modulates prefrontal cortical activity via the dopamine/D2 pathway

The "DTNBP1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DTNBP1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets